How are CAR-T cell therapies revolutionizing cancer treatment?
Chimeric Antigen Receptor T-cell (CAR-T) therapy is a groundbreaking immunotherapy where a patient's T-cells are genetically engineered to target and destroy cancer cells. CAR-T therapies have shown remarkable success in treating certain blood cancers, such as acute lymphoblastic leukemia and non-Hodgkin lymphoma. Ongoing research aims to expand the use of CAR-T therapies to solid tumors.
